Arbyn M et al (2020) Estimates of incidence and mortality of cervical cancer in 2018: a worldwide analysis. Lancet Glob Health 8(2):e191–e203

Article  PubMed  Google Scholar 

Kido A, Nakamoto Y (2021) Implications of the new FIGO staging and the role of imaging in cervical cancer. BJR 94(1125):20201342

Article  PubMed  PubMed Central  Google Scholar 

Wright JD et al (2019) Prognostic performance of the 2018 International Federation of Gynecology and Obstetrics cervical cancer staging guidelines. Obstet Gynecol Clin North Am 134(1):49

Google Scholar 

Cho O, Chun M (2018) Management for locally advanced cervical cancer: new trends and controversial issues. Radiat Oncol J 36(4):254

Article  PubMed  PubMed Central  Google Scholar 

Romei C et al (2021) New updates of the imaging role in diagnosis, staging, and response treatment of malignant pleural mesothelioma. Cancers 13(17):4377

Article  PubMed  PubMed Central  Google Scholar 

Rickard BP et al (2021) Malignant ascites in ovarian cancer: cellular, acellular, and biophysical determinants of molecular characteristics and therapy response. Cancers 13(17):4318

Article  CAS  PubMed  PubMed Central  Google Scholar 

Xie Y et al (2021) Automated clinical target volume delineation using deep 3D neural networks in radiation therapy of Non-small Cell Lung Cancer. Phys Imaging Radiat Oncol 19: p:131–137

Article  Google Scholar 

Gyamfi J, Kim J, Choi J (2022) Cancer as a metabolic disorder. IJMS 23(3):1155

Article  CAS  PubMed  PubMed Central  Google Scholar 

Jarrett AM et al (2018) Mathematical models of tumor cell proliferation: A review of the literature. Expert Rev Anticancer Ther 18(12):1271–1286

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chong LM et al (2021) Recent advances in radiation therapy and photodynamic therapy. Appl Phys Rev 8(4)

Abrantes AM et al (2020) Tumour functional imaging by PET. Biochimica Et Biophys Acta (bba)-molecular Basis Dis 1866(6):165717

Article  CAS  Google Scholar 

Cohen-Jonathan-Moyal É et al (2020) Radioresistant tumours: From identification to targeting. Cancer/Radiotherapie 24(6–7):699–705

Article  CAS  PubMed  Google Scholar 

Nestle U et al (2020) Imaging-based target volume reduction in chemoradiotherapy for locally advanced non-small-cell lung cancer (PET-Plan): a multicentre, open-label, randomised, controlled trial. Lancet Oncol 21(4):581–592

Article  CAS  PubMed  Google Scholar 

Specht L, Berthelsen AK (2018) PET/CT in radiation therapy planning. in Seminars in nuclear medicine. Elsevier

Google Scholar 

Alongi P et al (2019) Positron emission tomography with computed tomography imaging (PET/CT) for the radiotherapy planning definition of the biological target volume: PART 1. Crit Rev Oncol Hematol 140:74–79

Article  PubMed  Google Scholar 

Fonti R, Conson M, Del Vecchio S (2019) PET/CT in radiation oncology. in Seminars in oncology. Elsevier

Google Scholar 

Lohmann P et al (2020) PET/MRI radiomics in patients with brain metastases. Front Neurol 11: p:1

Article  Google Scholar 

Sarabhai T et al (2018) Simultaneous multiparametric PET/MRI for the assessment of therapeutic response to chemotherapy or concurrent chemoradiotherapy of cervical cancer patients: preliminary results. Clin Imaging 49: p:163–168

Article  Google Scholar 

Nguyen NC et al (2020) Diagnostic value of FDG PET/MRI in females with pelvic malignancy—a systematic review of the literature. Front Oncol 10: p:519440

Article  Google Scholar 

Sarabhai T et al (2018) Comparison of 18 F-FDG PET/MRI and MRI for pre-therapeutic tumor staging of patients with primary cancer of the uterine cervix. Eur J Nucl Med Mol Imaging 45:67–76

Article  PubMed  Google Scholar 

Nawapun S et al (2021) Correlation of clinical staging and MRI staging for cervical cancer. Egypt J Radiol Nucl Med 52:1–7

Article  Google Scholar 

Steiner A et al (2021) Diagnostic efficiency of whole-body 18F-FDG PET/MRI, MRI alone, and SUV and ADC values in staging of primary uterine cervical cancer. Cancer Imaging 21(1):1–11

Article  Google Scholar 

Martinez A et al (2020) Tumour and pelvic lymph node metabolic activity on FDG-PET/CT to stratify patients for para-aortic surgical staging in locally advanced cervical cancer. Eur J Nucl Med Mol Imaging 47:1252–1260

Article  CAS  PubMed  Google Scholar 

Cegla P et al (2019) Influence of 18F-FDG-PET/CT on staging of cervical cancer. Nuklearmedizin-NuclearMedicine 58(01):17–22

Article  Google Scholar 

Nguyen NC et al (2020) 18F-FDG PET/MRI primary staging of cervical cancer: a pilot study with PET/CT comparison. J Nucl Med Technol 48(4):331–335

Article  PubMed  Google Scholar 

Gong J et al (2019) Cervical cancer evaluated with integrated 18F-FDG PET/MR. Oncol Lett 18(2):1815–1823

CAS  PubMed  PubMed Central  Google Scholar 

Tsuyoshi H et al (2021) Diagnostic value of 18F-FDG PET/MRI for revised 2018 FIGO staging in patients with cervical cancer. Diagnostics 11(2):202

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wegen S et al (2023) First clinical experience with [68Ga] Ga-FAPI-46-PET/CT versus [18F] F‑FDG PET/CT for nodal staging in cervical cancer. Clin Nucl Med 48(2):150

Article  PubMed  Google Scholar 

Wong TZ, Jones EL, Coleman RE (2004) Positron emission tomography with 2‑deoxy-2-[(18)F]fluoro-D-glucose for evaluating local and distant disease in patients with cervical cancer. Mol Imaging Biol 6(1):55–62

Article  PubMed  Google Scholar 

Chou HH et al (2006) Low value of [18F]-fluoro-2-deoxy-D-glucose positron emission tomography in primary staging of early-stage cervical cancer before radical hysterectomy. J Clin Oncol 24(1):123–128

Article  PubMed  Google Scholar 

Kidd EA et al (2009) Cervical cancer histology and tumor differentiation affect 18F-fluorodeoxyglucose uptake. Cancer 115(15):3548–3554

Article  PubMed  Google Scholar 

Otani T et al (2023) Prognostic value of pretreatment FDG PET/CT in uterine cervical cancer according to two major histologic types: squamous cell carcinoma and adenocarcinoma. Asia Ocean J Nucl Med Biol 11(2):101

PubMed  PubMed Central  Google Scholar 

McComas KN et al (2020) The variable impact of positive lymph nodes in cervical cancer: Implications of the new FIGO staging system. Gynecol Oncol 156(1):85–92

Article  PubMed  Google Scholar 

Widschwendter P et al (2019) Prognostic factors for and pattern of lymph-node involvement in patients with operable cervical cancer. Arch Gynecol Obstet 300: p:1709–1718

Article  Google Scholar 

Bray F et al (2018) Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 68(6):394–424

Article  PubMed  Google Scholar 

Groheux D, Hindie E (2021) Breast cancer: initial workup and staging with FDG PET/CT. Clin Transl Imaging 9(3):221–231

Article  PubMed  PubMed Central  Google Scholar 

Holtkamp LH et al (2020) Staging 18F-FDG PET/CT influences the treatment plan in melanoma patients with satellite or in-transit metastases. Melanoma Res 30(4):358

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ohno Y et al (2023) Computed DWI MRI Results in Superior Capability for N‑Stage Assessment of Non-Small Cell Lung Cancer Than That of Actual DWI, STIR Imaging, and FDG-PET/CT. J Magn Reson Imaging 57(1):259–272